Teleflex
About: Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
Employees: 14,100
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
212% more call options, than puts
Call options by funds: $8.75M | Put options by funds: $2.81M
0.09% more ownership
Funds ownership: 101.55% [Q1] → 101.64% (+0.09%) [Q2]
6% less funds holding
Funds holding: 418 [Q1] → 394 (-24) [Q2]
14% less repeat investments, than reductions
Existing positions increased: 134 | Existing positions reduced: 156
18% less capital invested
Capital invested by funds: $6.5B [Q1] → $5.32B (-$1.19B) [Q2]
24% less first-time investments, than exits
New positions opened: 61 | Existing positions closed: 80
50% less funds holding in top 10
Funds holding in top 10: 2 [Q1] → 1 (-1) [Q2]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
|
Mizuho
Anthony Petrone
|
$135
|
Neutral
Maintained
|
1 Aug 2025 |
|
RBC Capital
Shagun Singh
|
$135
|
Sector Perform
Maintained
|
1 Aug 2025 |
|
Wells Fargo
Larry Biegelsen
|
$131
|
Equal-Weight
Maintained
|
1 Aug 2025 |
Financial journalist opinion
Based on 10 articles about TFX published over the past 30 days
